BEIJING (AP) — Drug manufacturer GlaxoSmithKline said Thursday it has investigated an accusation that its salespeople in China bribed doctors and found no evidence of wrongdoing.
The company said it conducted a four-month investigation after receiving complaints from an anonymous source. It said it found “no evidence of corruption or bribery in our China business.”
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.